Product Information
HYDROCHLOROTHIAZIDE 12.5 MG TB is a generic product labeled by Leading Pharma, LLC, priced at $0.0404 per EA under NDC 69315015510. Its NADAC has been published 339 times since Jan 1, 2020.
Strength
12.5 mg/1
Manufacturer
Leading Pharma, LLCNDC
69315015510
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
HYDROCHLOROTHIAZIDEApproval Type
Generic (ANDA)
FDA Application
ANDA040702On Market Since
11/1/2019
Pharmacological Classes
Price Statistics
The NADAC for HYDROCHLOROTHIAZIDE 12.5 MG TB has been published 339 times since Jan 1, 2020, and over the history we have for it it has declined 38.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0404 per EA |
|---|---|
| All-time high | $0.0840 (Jun 10, 2020) |
| All-time low | $0.0345 (Nov 20, 2024) |
| 52-week high | $0.0458 |
| 52-week low | $0.0403 |
| Median price | $0.0501 |
| Average price | $0.0534 |
| Largest weekly change | -28.3% (Nov 20, 2024) |
| Weeks tracked | 339 |
| Tracking since | Jan 1, 2020 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of HYDROCHLOROTHIAZIDE 12.5 MG TB?
The current National Average Drug Acquisition Cost (NADAC) for HYDROCHLOROTHIAZIDE 12.5 MG TB, manufactured by Leading Pharma, LLC, is $0.0404 per EA (NDC 69315015510), effective Jun 24, 2026.
How has the price of HYDROCHLOROTHIAZIDE 12.5 MG TB changed over time?
Over the history we have for it, the NADAC for HYDROCHLOROTHIAZIDE 12.5 MG TB has declined 38.3%. It has been tracked across 339 weekly CMS publications since Jan 1, 2020.
What are the highest and lowest recorded NADAC prices for HYDROCHLOROTHIAZIDE 12.5 MG TB?
Since Jan 1, 2020, the NADAC for HYDROCHLOROTHIAZIDE 12.5 MG TB has ranged from a low of $0.0345 (Nov 20, 2024) to a high of $0.0840 (Jun 10, 2020), with a median of $0.0501 per EA.
Are there cheaper alternatives to HYDROCHLOROTHIAZIDE 12.5 MG TB?
1 NADAC-published product shares the same active ingredient, strength, and dosage form as HYDROCHLOROTHIAZIDE 12.5 MG TB, but none are currently priced below it.
Who manufactures HYDROCHLOROTHIAZIDE 12.5 MG TB?
HYDROCHLOROTHIAZIDE 12.5 MG TB (NDC 69315015510) is labeled by Leading Pharma, LLC, and CMS classifies it as a generic product.
Related Drugs
Same classification